| Display title | Chemistry:Endrisone |
| Default sort key | Endrisone |
| Page length (in bytes) | 3,570 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 489937 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>OrgMain |
| Date of page creation | 15:17, 4 February 2023 |
| Latest editor | imported>OrgMain |
| Date of latest edit | 15:17, 4 February 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Endrisone (INN) (brand name Aldrisone), or endrysone (USAN), is a synthetic, steroidal glucocorticoid which is or has been marketed in Italy by SIFI. It is used as a topical and ophthalmic anti-inflammatory drug in the treatment of skin and eye conditions, respectively. |
